Structure-chiroptical properties relationship in oxabicyclic β-lactam derivatives

Enantiomer

Volumn 7, Issue 2-3, 2002, Pages 107-114

  Frelek, Jadwiga ^a   Łysek, Robert ^a   Borsuk, Katarzyna ^a   Jagodziński, Jacek ^b   Furman, Bartłomiej ^a   Klimek, Agata ^a   Chmielewski, Marek ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Poland)

^b DIONEX CORPORATION   (United States)

Author keywords

5 dethia 5 oxacephams; Circular dichroism; Clavams; Molecular modelling calculation; Molecular structure

Indexed keywords

1 OXACEPHEM DERIVATIVE; AMIDE; BETA LACTAM ANTIBIOTIC; BETA LACTAM DERIVATIVE; BETA LACTAMASE; CARBON; NITROGEN; ANTIINFECTIVE AGENT; BETA LACTAM; BICYCLO COMPOUND;

ANTIBACTERIAL ACTIVITY; ARTICLE; CALCULATION; CHEMICAL STRUCTURE; CHIRALITY; CHROMATOPHORE; CIRCULAR DICHROISM; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG STRUCTURE; ENZYME INHIBITION; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STEREOCHEMISTRY; STRUCTURE ANALYSIS; X RAY ANALYSIS; X RAY DIFFRACTION; CHEMISTRY; DRUG ANTAGONISM; OPTICAL ROTATION; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; BICYCLO COMPOUNDS; CIRCULAR DICHROISM; MOLECULAR STRUCTURE; OPTICAL ROTATION; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; X-RAY DIFFRACTION;

EID: 0036490314     PISSN: 10242430     EISSN: None     Source Type: Journal    
DOI: 10.1080/10242430212200     Document Type: Article

References (48)

1. R. D. G. Cooper, in P. G. Sammes (ed.), Topics in Antibiotics Chemistry, Ellis Horwood Ltd.: Chichester, 1980, vol. 3, p. 39;
2. R. B. Morin and M. G. Gorman (eds.), Chemistry and Biology of β-Lactams Antibiotics, Academic Press: New York, 1982, vol. 1, 2, 3;
3. W. Dürckheimer, J. Blumbach, R. Lattrell, and K. H. Scheunemann, Angew. Chem., Int. Ed. Engl. 1985, 24, 180;
4. G. I. Georg (ed.), The Organic Chemistry of β-Lactams, VCh: New York, 1993;
5. G. I. Georg (ed.), Recent Advances in the Chemistry and Biology of β-Lactams and β-Lactams Antibiotics, Bioorg. Med. Chem. Lett. (Symposia-in-print No 8), 1993, 3, 2159.
6. A. G. Brown, D. Butterworth, M. Cole, G. Hanscomb, J. D. Hood, C. Reading, and G. N. Rolinson, J. Antibiot. 1976, 29, 668;
7. T. T. Howarth, A. G. Brown, and T. J. King, J. Chem. Soc., Chem. Commun. 1976, 266;
8. A. G. Brown, D. F Corbett, J. Goodacre, J. B. Harbridge, T. T. Howarth, R. J. Ponsford, I. Stirling, and T. J. King, J. Chem. Soc. Perkin Trans 1, 1984, 635.
9. S. Oida, A. Yoshida, and E. Ohki, Chem. Pharm. Bull. 1978, 26, 448;
10. J. E. Baldwin, R. M. Adlington, J. S. Bryans, A. O. Bringhen, J. B. Coates, N. R Crouch, M. D. Lloyd, C. J. Schofield, S. W. Elson, K. H. Baggaley, R. Cassels, and N. Nicholson, Tetrahedron 1991, 47, 4089.
11. O. Neuß, B. Furman, Z. Kałuza, and M. Chmielewski, Heterocycles 1997, 45, 265.
12. D. Brown, J. R. Evans, and R. A. Fletton, J. Chem. Soc., Chem. Commun. 1979, 282;
13. M. Wanning, H. Zähner, B. Krone, and A. Zeeck, Tetrahedron Lett. 1981, 22, 2539;
14. D. L. Pruess and M. Kellett, J. Antibiot. 1983, 36, 208;
15. R. H, Jr Evans, H. Ax, A. Jacoby, T. H. Williams, E. Jenkins, and J. P. Scannell, J. Antibiot. 1983, 36, 213;
16. H. D. King, J. Langhärig, and J. J. Sanglier, J. Antibiot. 1986, 39, 510;
17. H. V. Naegeli, H.-R. Loosli, and A. Nussbaumer, J. Antibiot. 1986, 39, 516.
18. M. Murakami, T. Aoki, M. Matsuura, and W. Nagata, J. Antibiot. 1990, 43, 1441;
19. H. R. Pfaendler, W. Hendel, and U. Nagel, Z. Naturforsch. Teil B. 1992, 47, 1037;
20. H. R. Pfaendler, T. Neumann, and R. Bartsch, Synthesis 1992, 1179;
21. H. Wild and W. Hartwig, Synthesis 1992, 1099;
22. H. Wild and K.-G. Metzger, Bioorg. Med. Chem. Lett. 1993, 3, 2205;
23. H. R. Pfaendler, F. Weisner, and K. Metzger, Bioorg. Med. Chem. Lett. 1993, 3, 2211.
24. L. D. Cama and B. G. Christensen, J. Am. Chem. Soc. 1974, 96, 7582;
25. R. A. Firestone, J. L. Fahey, N. S. Maciejewicz, G. S. Patel, and B. G. Christensen, J. Med. Chem. 1977, 20, 551;
26. S. Shibahara, T. Okonogi, Y. Murai, T. Kudo, T. Yoshida, S. Kondo, and B. G. Christensen, J. Antibiot. 1988, 41, 1154.
27. W. Nagata, Pure Appl. Chem. 1989, 61, 325;
28. W. Nagata, M. Narisada, and T. Yoshida, in R. B. Morin and M. G. Gorman (eds.), Chemistry and Biology of β-Lactam Antibiotics, Academic Press: New York, 1982, vol. 2, p. 1;
29. Y. Aoyama, M. Uenaka, T Konoike, Y. Iso, Y. Nishitani, A. Kanda, N. Naya, and M. Nakajima, Bioorg. Med. Chem. Lett. 2000, 10, 2397;
30. Bioorg. Med. Chem. Lett. 2000, 10, 2403.
31. T. Okonogi, S. Shibahara, Y. Murai, S. Inouye, and S. Kondo, Heterocycles 1990, 31, 791.
32. B. Furman, Z. Kałuza, and M. Chmielewski, J. Org. Chem. 1997, 62, 3135.
33. B. Furman, P. Krajewski, Z. Urbańczyk-Lipkowska, J. Frelek, Z. Kałuza, L. Kozerski, and M. Chmielewski, J. Chem. Soc., Perkin Trans 2 1998, 1737.
34. R. Łysek, B. Furman, Z. Kałuza, J. Frelek, K. Suwińska, Z. Urbańzyk-Lipkowska, and M. Chmielewski, Tetrahedron: Asymmetry 2000, 11, 3131.
35. Z. Kałuza, B. Furman, P. Krajewski, and M. Chmielewski, Tetrahedron 2000, 56, 5553.
36. R. Łysek, K. Borsuk, M. Chmielewski, Z. Kałuza, Z. Urbańczyk-Lipkowska, A. Klimek, and J. Frelek, J. Org. Chem. in press.
37. P. H. Bentley and E. Hunt, J. Chem. Soc., Perkin Trans 1 1980, 2222.
38. R. Busson, E. Roets, and H. Vanderhaeghe, Chiroptical studies of penicillanates in J. Elks (ed.), Recent Advances in the Chemistry of β-Lactam Antibiotics, Chem. Soc.: London 1977, p. 304;
39. R. Busson and H. Vanderhaeghe, J. Org. Chem. 1978, 43, 4438.
40. K. Borsuk and M. Chmielewski, unpublished results.
41. K. Borsuk, K. Suwińska, and M. Chmielewski, Tetrahedron: Asymmetry 2001, 12, 979.
42. Z. Kałuza, B. Furman, M. Patel, and M. Chmielewski, Tetrahedron: Asymmetry 1994, 5, 2179.
43. R. Łysek, Z. Urbańczyk-Lipkowska, and M. Chmielewski, Tetrahedron 2001, 57, 1301.
44. R. Łysek, B. Furman, M. Cierpucha, Ł. Matyjasek, and M. Chmielewski, unpublished results.
45. Z. Kałuza, B. Furman, and M. Chmielewski, Tetrahedron: Asymmetry 1995, 7, 1719.
46. CS ChemOffice Ultra suite of applications by Cambridge-Soft Corp. 2000.
47. Spartan Pro Molecular Modelling package, v1.0.4 by Wavefunction, Inc. 2000.
48. Use of the PM3 method led to the molecular geometry that was generally closer to that obtained from X-ray diffraction than respective geometries resulted from calculations done using AM1 or MNDO/3 methods.